Published in AIDS Weekly, January 14th, 2002
"Early assessment of antiretroviral drug efficacy is important for prevention of the emergence of drug-resistant virus and unnecessary exposure to ineffective drug regimens," according to Dr. Michael A. Polis and colleagues at the National Institutes of Health in Bethesda and the National Cancer Institute in Frederick, Maryland, the Texas Children's Cancer Center at Baylor College in Houston, Texas, and Stanford University in Stanford, California. "Current U.S. guidelines for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.